Jefferies lowered its price target on CVS Health (NYSE: CVS) to $76.00 (from $86.00) while maintaining a Hold ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

CVS Health (CVS) PT Lowered to $85 at Leerink PartnersNovember 7, 2017 7:48 AM McKesson (MCK) to Acquire RxCrossroads for $735MNovember 6, 2017 4:21 PM McKesson Strengthens Its Portfolio of Manufacturer Solutions with the Acquisition of RxCrossroadsNovember 6, 2017 4:16 PM CVS Pharmacy to Bring Prescriptions Right to Customers' Doors with Nationwide Next-Day Delivery and Same-Day Delivery in Select MarketsNovember 6, 2017 10:28 AM CVS Health (CVS) Tops Q3 EPS by 1c; Narrows EPS Outlook, Raising MidpointNovember 6, 2017 6:59 AM CVS Health Reports Third Quarter ResultsNovember 6, 2017 6:55 AM Anthem top executive Swedish to become adviser, Boudreaux named CEONovember 6, 2017 6:18 AM Anthem CEO Joseph Swedish to step down, Gail Boudreaux to succeed: WSJNovember 3, 2017 7:11 PM CVS, Aetna aim to finalize deal as early as December: sourcesNovember 3, 2017 3:15 PM CVS Health (CVS), Aetna (AET) Aim to Finalize Deal as Early as December - Reuters November 3, 2017 3:11 PM CVS Health (CVS) IV elevated as shares near three-year low into Q3November 3, 2017 11:03 AM Apple juices Wall St. as indexes climb for another weekNovember 3, 2017 7:32 AM